Organoid Models for Precision Cancer Immunotherapy
Cancer immunotherapy is exploited for the treatment of disease by modulating the immune system. Since the conventional in vivo animal and 2D in vitro models insufficiently recapitulate the complex tumor immune microenvironment (TIME) of the original tumor. In addition, due to the involvement of the...
Main Authors: | Cai-Ping Sun, Huan-Rong Lan, Xing-Liang Fang, Xiao-Yun Yang, Ke-Tao Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.770465/full |
Similar Items
-
Breast cancer organoids and their applications for precision cancer immunotherapy
by: Dandan Guan, et al.
Published: (2023-10-01) -
Patient-Derived Tumor Organoids: New Progress and Opportunities to Facilitate Precision Cancer Immunotherapy
by: Ji Wang, et al.
Published: (2022-04-01) -
Integration of Tumor Microenvironment in Patient-Derived Organoid Models Help Define Precision Medicine of Renal Cell Carcinoma
by: Bingran Wang, et al.
Published: (2022-05-01) -
Will Organoids Fill the Gap towards Functional Precision Medicine?
by: Federica Papaccio, et al.
Published: (2022-11-01) -
Establishment of tumor microenvironment-preserving organoid model from patients with intracranial meningioma
by: Dokyeong Kim, et al.
Published: (2024-01-01)